NASDAQ:INMB

Inmune Stock Predictions

Healthcare > Biotechnology

Buy INMB

*Your capital is at risk

$1.32

-0.1000 (-7.04%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

INMB Prediction Chart

INMB Predictions History

Latest community submissions for INMB.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Aug 28, 2019	$6.09 -4.55%	$6.38	X	95.45%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for INMB with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT INMUNE BIO INC.

INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma and patients with high-risk myelodysplastic synd...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by